Key TakeawaysNew research found the body’s immune system reacts differently in people with severe and mild forms of COVID-19.If scientists can better understand what the best immune response is, they may be able to assist the immune system in developing that response in the future.Researchers say this data may help influence future treatments for the virus.
Key Takeaways
New research found the body’s immune system reacts differently in people with severe and mild forms of COVID-19.If scientists can better understand what the best immune response is, they may be able to assist the immune system in developing that response in the future.Researchers say this data may help influence future treatments for the virus.
Scientists in the U.K. have identified differences in the immune responses between people with asymptomatic cases of COVID-19 and those who had a serious reaction to the virus.
The April study, which was published in the journalNature Medicine,found higher levels of certain immune cells in people with COVID-19 who did not have symptoms. Researchers also found that people who had more serious forms of COVID-19 did not have elevated levels of these protective immune cells, and also gained inflammatory cells.
COVID-19 and Pre-Existing Conditions: Understanding Your Risk
In people with asymptomatic cases, the researchers found increased levels of B cells, which produce antibodies that are found in mucus passages like the nose. These cells are thought to be protective against COVID-19. But those same cells were missing in people with severe cases, suggesting that this function of the immune response failed.
This, the researchers say, could help explain why people with severe forms of COVID-19 are at risk of developing lung inflammation and blood clots.
Why It’s Important to Understand Immune Responses
There are a few reasons why it’s crucial to examine the immune responses in COVID-19 patients, senior study authorMuzlifah Haniffa, PhD, a professor at Newcastle University and senior clinical fellow at the Wellcome Sanger Institute, tells Verywell. “One is to know how the body fights off an infection successfully,” she says. “The other is to know how the immune response can be damaging to an individual.”
That, Haniffa says, is important in finding new ways to successfully treat COVID-19, especially in patients with severe forms of the disease.
When people get severely ill from COVID-19 “it is not from an overwhelming viral infection, it is more likely a big infection coupled with a particular immune response to that infection,” Giordano says. “If we can better understand what the best immune response is—not too weak, not too strong, but just right—maybe we can assist the immune system in having that best response and avoiding harmful responses.”
What This Means For You
What Does This Mean for Treatment?
While the findings won’t exactly predict who will have a severe reaction to COVID-19, it may help doctors determine who won’t react as well to existing treatments for COVID-19. “Those patients who have a higher proportion of a particular type of ‘B cell,’ the cells which produce antibodies to neutralize the virus, may respond less well [to certain medications],” lead study authorEmily Stephenson, a PhD student at Newcastle University, tells Verywell.
COVID-19 Treatments: What You Need to Know
David Cennimo, MD, assistant professor of medicine-pediatrics infectious disease at Rutgers New Jersey Medical School, tells Verywellthat “understanding the immune response would help predict who may have a severe infection and how to best modify their responses for optimal outcome.”
He gives the example of the immunosuppressant tocilizumab. “It appears to have some benefits in those patients with very high inflammation markers,” he says. “It is like we are treating different illnesses. One is the direct viral invasion of cells; the other is the host response to the infection which may become more damaging than the infection itself.”
Corticosteroids Should Be First Line of Treatment For Severe COVID-19, WHO Says
While doctors can’t predict right now how strongly the virus will impact any given person, Cennimo says he “could imagine a future where we can fine-tune our medications to the individual’s levels of immune activation.”
The researchers didn’t analyze vaccinated people as part of their study, but Haniffa says their data may be useful for vaccine development in the future.
The information in this article is current as of the date listed, which means newer information may be available when you read this. For the most recent updates on COVID-19, visit ourcoronavirus news page.
1 SourceVerywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Stephenson E, Reynolds G, Botting RA, et al.Single-cell multi-omics analysis of the immune response in COVID-19.Nature Medicine. doi:10.1038/s41591-021-01329-2
1 Source
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Stephenson E, Reynolds G, Botting RA, et al.Single-cell multi-omics analysis of the immune response in COVID-19.Nature Medicine. doi:10.1038/s41591-021-01329-2
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Stephenson E, Reynolds G, Botting RA, et al.Single-cell multi-omics analysis of the immune response in COVID-19.Nature Medicine. doi:10.1038/s41591-021-01329-2
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
